The goal of this clinical trial is to investigate the impact of a 10-week moderate intensity interval walking training (MIIWT) program on kidney function markers in obese postmenopausal women. The main question it aims to answer is: Does MIIWT improve kidney function markers in this population? Researchers will compare MIIWT (designed to training group) to non-training intervention (designed to control group) to see if the training program works to improve kidney function markers. Participants in training group will: perform a 10-week MIIWT program, four sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 60-80% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Participants in control group will : not perform any physical training and maintain their usual daily activities.
Age range
50 Years – 60 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
serum creatinine
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
blood urea nitrogen
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
serum uric acid
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
glomerular Filtration Rate
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
white blood cells count
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
neutrophils
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
lymphocytes
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
monocytes
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
eosinophils
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).
basophils
Timeframe: At baseline and at week 11(after the ten weeks of the training intervention).